Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Controlled Release Of Insulin And Modified Insulin From A Novel Injectable Biodegradable Gel

O. Anand
Published 2008 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
The structure and sequence of insulin
U Derewenda (1993)
10.3891/ACTA.CHEM.SCAND.10-1455
Insulin Crystals. I. The Minimum Mole-Fraction of Metal in Insulin Crystals Prepared with Zn++, Cd++, Co++, Ni++, Cu++, Mn++, or Fe++.
J. Schlichtkrull (1956)
10.1016/0303-7207(90)90142-U
Characterization of insulin degradation products generated in liver endosomes: In vivo and in vitro studies
J. Clot (1990)
10.1021/JS9701768
Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue.
P. Kurtzhals (1997)
The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.
M. White (1998)
10.2337/diab.34.12.1247
HLA Heterogeneity of Insulin-dependent Diabetes Mellitus at Diagnosis: The Pittsburgh IDDM Study
M. Eberhardt (1985)
10.1021/BI9625105
Crystal structure of a prolonged-acting insulin with albumin-binding properties.
J. L. Whittingham (1997)
10.2337/diab.46.2.161
The Role of Enteroviral Infections in the Development of IDDM: Limitations of Current Approaches
P. Graves (1997)
AUTOMATION CONTROL OF BLOOD SUGAR. I. A SERVOMECHANISM FOR GLUCOSE MONITORING AND CONTROL.
A. H. Kadish (1964)
10.1016/0002-9343(88)90399-3
Hepatic metabolism of insulin.
W. Duckworth (1988)
10.1002/JBM.B.30372
Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
S. Sajeesh (2006)
10.1248/CPB.50.749
Phospholipid deformable vesicles for buccal delivery of insulin.
Tian-zhi Yang (2002)
10.1016/0010-4809(70)90021-2
A mathematical model for the control mechanism of free fatty acid-glucose metabolism in normal humans.
R. Srinivasan (1970)
Controlled release of insulin from a novel biodegradable injectable gel system.2006
Q. Chen (2007)
10.1248/BPB.28.1801
Evaluation of snail mucin motifs as rectal absorption enhancer for insulin in non-diabetic rat models.
M. Adikwu (2005)
10.2527/JAS1982.54158X
The role of insulin-receptor interactions in regulation of nutrient utilization by skeletal muscle and adipose tissue: a review.
T. Etherton (1982)
10.1038/338594A0
Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer
U. Derewenda (1989)
10.1016/S0140-6736(84)91517-4
RELATION BETWEEN BREAST-FEEDING AND INCIDENCE RATES OF INSULIN-DEPENDENT DIABETES MELLITUS: A Hypothesis
K. Borch-Johnsen (1984)
10.3109/9780203301036
Pharmaceutical Biotechnology: An Introduction for Pharmacists and Pharmaceutical Scientists
D. J. Crommelin (1997)
10.1016/S0378-5173(99)00227-6
Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
M. Yun (1999)
10.3109/10717549809052026
Pulsatile insulin delivery through the ocular route.
V. Soni (1998)
10.1002/JPS.2600790610
Sustained release of insulin by double-layered implant using poly(D,L-lactic acid).
I. Yamakawa (1990)
Renal metabolism of peptide hormones.
R. Rabkin (1983)
Stability of insulin : studies on the physical and chemical stability of insulin in pharmaceutical formulation
J. Brange (1994)
10.1210/EDRV.19.5.0349
Insulin degradation: progress and potential.
W. Duckworth (1998)
10.1002/dmrr.317
An overview of insulin glargine
P. Home (2002)
10.1016/S0168-3659(03)00196-2
Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate.
Silvia Surini (2003)
Automation control of blood sugar a servomechanism for glucose monitoring and control.
Kadish Ah (1963)
10.1016/0022-0248(92)90237-D
Mutant insulin crystal packing
B. Xiao (1992)
10.1021/JA00907A027
Insulin Peptides. VIII. A Synthetic Heptadecapeptide Derivative Corresponding to the C-Terminal Sequence of the B-Chain of Insulin
P. Katsoyannis (1963)
10.1021/JA00901A052
Insulin Peptides. IX. The Synthesis of the A-Chain of Insulin and its Combination with Natural B-Chain to Generate Insulin Activity
P. Katsoyannis (1963)
10.2337/diab.38.5.550
Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM
A. Consoli (1989)
The Buccal Delivery of Insulin
10.1016/S0969-2126(01)00195-2
Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin.
E. Ciszak (1995)
Insulin glargine. Drugs
PS Gillies (2000)
10.1007/s11095-005-9047-1
Biochemical and Physiological Properties of a Novel Series of Long-Acting Insulin Analogs Obtained by Acylation with Cholic Acid Derivatives
I. Jonassen (2005)
10.1081/DDC-100102234
Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil, and their combinations in diabetic rabbits.
E. A. Hosny (1999)
10.2174/1389557023406007
Biomembrane permeability of peptides: strategies to improve their mucosal uptake.
A. Bernkop-Schnürch (2002)
10.1081/DDC-120018644
Potential Applications of Polymeric Microsphere Suspension as Subcutaneous Depot for Insulin
D. Shenoy (2003)
10.1002/JPS.10355
Prediction of the association state of insulin using spectral parameters.
V. Uversky (2003)
10.1016/J.IJPHARM.2005.04.016
A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
A. Cilek (2005)
10.1007/s11095-005-9175-7
Novel Mucosal Insulin Delivery Systems Based on Fusogenic Liposomes
T. Goto (2005)
Synthesis of the insulin chain and the combination to insulin active preparation
J Meienhofer (1963)
10.1211/0022357055434
Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model
M. Lane (2005)
10.3891/ACTA.CHEM.SCAND.10-1459
Insulin Crystals. II. Shape of Rhombohedral Zinc-Insulin Crystals in Relation to Species and Crystallization Media.
J. Schlichtkrull (1956)
10.1021/IE50367A010
Preparation of Crystalline Insulin
R. G. Romans (1940)
10.1016/0142-9612(91)90133-U
Palmitic acid as an excipient in implants for sustained release of insulin.
P. Wang (1991)
10.1016/S0169-409X(98)00073-8
Intranasal insulin delivery and therapy.
Hinchcliffe (1999)
[Studies on new insulin preparations with retarded effect].
K. HALLAS-MØLLER (1953)
10.2165/00003495-200666060-00011
Insulin Glulisine
D. Robinson (2006)
Semisynthesis of human insulin: trypsin-catalyzed replacement of alanine B30 by threonine in porcine insulin
K Morihara (1979)
inventors; (Novo Terapeutisk Laboratorium A/S). assignee. Injectable insulin with depot action
K Hallas-Moller (1956)
10.1081/PDT-100100513
Porcine Insulin Biodegradable Polyester Microspheres: Stability and In Vitro Release Characteristics
P. Shao (2000)
10.1016/S0378-5173(01)00602-0
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
R. Soane (2001)
10.2337/dc06-2408
Flexible Intensive Insulin Therapy in Adults With Type 1 Diabetes and High Risk for Severe Hypoglycemia and Diabetic Ketoacidosis
A. Saemann (2007)
10.1007/s001250050514
Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY)
M. Rewers (2009)
10.1023/B:PHAM.0000008050.99985.5c
Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats
Suna Choi (2004)
10.1016/S0140-6736(95)91270-3
Coxsackie B virus infection and onset of childhood diabetes
G. Clements (1995)
10.1042/BJ2490209
Identification of radioactive insulin fragments liberated by insulin proteinase during the degradation of semisynthetic [3H]GlyA1]insulin and [3H]PheB1]insulin.
J. G. Davies. (1988)
10.1021/IE50183A004
THE PREPARATION OF INSULIN
C. Best (1925)
10.1016/J.JCONREL.2006.04.012
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
10.1089/JOP.1994.10.683
Insulin administration to the eyes of normoglycemic human volunteers.
J. D. Bartlett (1994)
10.1007/s001250051529
Oral delivery of glucagon-like peptide-1 in a modified polymer preparation normalizes basal glycaemia in diabetic db/db mice
J. Joseph (2000)
10.2337/diab.29.1.37
One Month of Sustained Release of Insulin from a Polymer Implant
H. M. Creque (1980)
[SYNTHESIS OF INSULIN CHAINS AND THEIR COMBINATION TO INSULIN-ACTIVE PREPARATIONS].
J. Meienhofer (1963)
10.1023/A:1011074915438
Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer
Y. Kim (2004)
10.1016/0896-8411(95)90001-2
Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation.
J. F. Bach (1995)
inventors; (The Jordanian Pharmaceutical Manufacturing Co., Jordan; Terramark Markencreation GmbH). assignee. Oral delivery of protein drug using microemulsion. Application: WO patent
AA Badwan (2007)
10.1142/9789810248543_0007
The Nobel Prize in Physiology or Medicine
J. Lindsten (2001)
10.1016/J.EJPS.2004.03.001
Assuring quality and performance of sustained and controlled released parenterals.
D. Burgess (2004)
10.1093/OXFORDJOURNALS.BMB.A072320
Molecular structure of insulin: the insulin monomer and its assembly.
U. Derewenda (1989)
10.1042/BJ2400609
Identification of some cleavage sites of insulin by insulin proteinase.
J. G. Davies. (1986)
10.1073/PNAS.75.7.3070
Insulin receptor: interaction with nonreceptor glycoprotein from liver cell membranes.
J. Maturo (1978)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1211/0022357991776976
Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside
T. Uchiyama (1999)
10.1016/S0142-9612(00)00039-9
Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
M. Marschütz (2000)
10.1023/A:1012095115151
Assembly and Dissociation of Human Insulin and LysB28ProB29-Insulin Hexamers: A Comparison Study
D. Birnbaum (2004)
10.1023/A:1026118813943
Pulmonary Absorption of Insulin Mediated by Tetradecyl-β-Maltoside and Dimethyl-β-Cyclodextrin
Alamdar Hussain (2004)
Pancreatic extracts. 1922.
F. Banting (1990)
Recent developments in insulin delivery techniques. Current status and future potential.
F. Kennedy (1991)
10.1007/s001250050735
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance
S. D. Prato (1997)
10.1172/JCI111533
Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
C. Bogardus (1984)
10.1126/science.157.3789.697
Insulin Biosynthesis: Evidence for a Precursor
D. Steiner (1967)
Insulin chemistry and pharmacokinetics
C Binder (2003)
[Clinical studies on new insulin preparations with prolonged action; one daily injection with insulin zinc preparations].
K. HALLAS-MØLLER (1951)
10.2165/00003495-200464110-00001
Evolving Strategies for Insulin Delivery and Therapy
W. Cefalu (2012)
10.1016/S0168-3659(03)00263-3
Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs.
K. Surendrakumar (2003)
10.1081/PDT-100101402
Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres.
P. Shao (1999)
10.1126/SCIENCE.129.3359.1340
Chemistry of insulin; determination of the structure of insulin opens the way to greater understanding of life processes.
F. Sanger (1959)
10.1016/J.EJPS.2004.02.007
Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
Jai-Hyun Kwon (2004)
10.1016/S1043661802002049
Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.
H. Xu (2002)
10.1152/AJPENDO.1992.263.4.E772
Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state.
Toyohiko Morishima (1992)
Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization.
P. Venugopalan (2001)
Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.
N. Boute (2001)
inventors; (Beckman Instruments, Inc.). assignee. Measurement of glucose concentration in blood
DA Hall (1972)
10.1016/S0065-3233(08)60143-6
Insulin: The Structure in the Crystal and its Reflection in Chemistry and Biology by
T. Blundell (1972)
The Nobel Prize in Physiology or Medicine, 1901-2000
J. Lindsten (2000)
10.1016/S0378-5173(00)00615-3
Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin.
M. Morishita (2001)
10.1016/J.ADDR.2003.08.011
Closed-loop insulin delivery-the path to physiological glucose control.
G. Steil (2004)
10.1210/ENDO.133.4.8404592
Degradation of insulin by isolated rat renal cortical endosomes.
J. Fawcett (1993)
10.1073/PNAS.69.12.3698
Purification of insulin-specific protease by affinity chromatography.
W. Duckworth (1972)
10.1016/S0378-5173(01)00662-7
Effect of additives on insulin absorption from intratracheally administered dry powders in rats.
H. Todo (2001)
10.1016/S0142-9612(00)00050-8
Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions.
T. Traitel (2000)
10.1016/S0169-409X(98)00071-4
Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) - genetic predisposition and metabolic abnormalities.
Jun. (1999)
10.1080/10717540500313109
Lecithin-Based Microemulsion of a Peptide for Oral Administration: Preparation, Characterization, and Physical Stability of the Formulation
A. Cilek (2006)
10.1016/S0939-6411(00)00144-2
Factors and strategies for improving buccal absorption of peptides.
F. Veuillez (2001)
Diabetes in the New Millennium
J. R. Turtle (1999)
Structure-function studies with chemically modified insulins
D Brandenburg (1973)
The history of diabetes.
V. Coleman (1975)
10.7326/0003-4819-143-8-200510180-00005
Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes
J. Rosenstock (2005)
10.1021/ja00497a051
Enzyme-assisted semisynthesis of human insulin
K. Inouye (1979)
10.1515/BCHM3.1987.368.2.903
Phenol-promoted structural transformation of insulin in solution.
A. Wollmer (1987)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
10.1023/B:PHAM.0000016248.30579.2f
Biodegradable Triblock Copolymer Microspheres Based on Thermosensitive Sol-Gel Transition
Y. M. Kwon (2004)
10.1002/1520-6017(200101)90:1<89::AID-JPS10>3.0.CO;2-A
Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.
H. Tozaki (2001)
10.1007/BF00400925
Coxsackie B virus IgM in children at onset of Type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection
G. Frisk (2004)
10.1016/S0378-5173(99)00119-2
Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats.
J. Barichello (1999)
10.1093/AJHP/62.8.816
Properties of pramlintide and insulin upon mixing.
C. Weyer (2005)
10.2337/DIACARE.28.8.1922
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
R. DeFronzo (2005)
10.1021/BI9903188
Role of metal ions in the T- to R-allosteric transition in the insulin hexamer.
W. Kadima (1999)
10.1248/BPB.16.182
Controlled release of insulin from plasma-irradiated sandwitch device using poly-DL-lactic acid.
I. Yamakawa (1993)
10.1042/BJ2490215
Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase.
L. Savoy (1988)
10.1210/ENDO-116-3-926
Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
F. Stentz (1985)
10.1016/0022-2836(92)90323-C
Role of B13 Glu in insulin assembly. The hexamer structure of recombinant mutant (B13 Glu-->Gln) insulin.
G. A. Bentley (1992)
10.1089/15209150260007372
Inhaled insulin and insulin antibodies: a new twist to an old debate.
J. Stoever (2002)
inventor (Novo Terapeutisk Laboratorium A/S)
J Schlichtkrull (1961)
10.2337/diab.37.6.667
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
R. DeFronzo (1988)
10.1016/S0939-6411(96)00017-3
Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients
M. Morlock (1997)
10.1007/s00125-005-1843-y
There really is an epidemic of type 2 diabetes
S. Colagiuri (2005)
10.1106/R3TF-PT7W-DWN0-1RBL
Gellan Film as an Implant for Insulin Delivery
J. Li (2001)
10.1055/S-2005-837662
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.
R. Ratner (2005)
10.1111/j.2042-7158.1988.tb07001.x
External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats
S. Miyazaki (1988)
10.1016/S0140-6736(54)90601-7
Chemical, biological, and physiological background of the new insulin-zinc suspensions.
K. Hallas-Møller (1954)
10.1001/JAMA.1952.03680170021006
Zinc insulin preparations for single daily injection; clinical studies of new preparations with prolonged action.
K. Hallas-Møller (1952)
10.1001/ARCHINTE.163.15.1781
Benefits of combination therapy of insulin and oral hypoglycemic agents.
A. Garber (2003)
Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres.
Yan Pan (2002)
10.1016/S0168-3659(99)00048-6
Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.
Y. Kawashima (1999)
Advances in the oral delivery of heparin from solid dosage forms using emisphere's eligen oral drug delivery technology
S. Majuru (2004)
10.1016/S0065-7743(00)35020-5
Chapter 19. Recent advances in therapeutic approaches to type 2 diabetes
J. M. Nuss (2000)
Insulin lispro: a review of its use in the management of diabetes mellitus.
D. Simpson (2007)
Development of an oral insulin solid dosage formulation using Emisphere's eligen technology
S. Majuru (2005)
10.1016/S0378-5173(98)00367-6
Evaluation of the clearance characteristics of bioadhesive systems in humans.
R. Soane (1999)
10.1007/BF00400989
Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver
H. Sato (2004)
Pathogenesis of non-insulin dependent diabetes mellitus
V. Grill (1988)
[Clinical investigations on new preparations of prolonged action insulin; zinc-insulin preparation for daily injection].
M. Jersild (1954)
10.1073/PNAS.12.2.132
Crystalline Insulin.
J. J. Abel (1926)
THE EFFECT OF ZINC SALTS ON THE ACTION OF INSULIN
D. Scott (1935)
10.1126/SCIENCE.116.3015.394
Crystalline and amorphous insulin-zinc compounds with prolonged action.
K. Hallas-Møller (1952)
10.1016/S0168-3659(02)00024-X
Modulated insulin permeation across a glucose-sensitive polymeric composite membrane.
K. Zhang (2002)
10.1016/S0140-6736(00)03631-X
Two cheers for inhaled insulin
E. Gale (2001)
10.1016/0304-4165(91)90213-Z
Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.
H. Sato (1991)
10.1007/BF02221682
Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland
J. Kaprio (2005)
10.1023/A:1006806722619
The IRS-signalling system: A network of docking proteins that mediate insulin action
M. White (2004)
Report on recent calculations on rhombohedral insulin crystals containing lead
MJ Adams (1967)
Combinaciones cristalinas y amorfas de insulina-zinc de accion prolongada
K Hallas-Moller (1954)
inventors; (Governors of The University of Toronto). assignee. Therapeutic composition containing insulin
DA Scott (1939)
Insulin detemir: a new basal insulin analogue
Zou Ding (2007)
Effect of Fatty Acids and Selected Drugs on the Albumin Binding of a Long-Acting, Acylated Insulin Analog
P Kurtzhals (1997)
10.1016/J.JCONREL.2006.01.015
New loading process and release properties of insulin from polysaccharide microcapsules fabricated through layer-by-layer assembly.
S. Ye (2006)
10.1111/j.1464-5491.2004.01285a.x
A review of basal insulins
E. Chantelau (2004)
10.1210/ENDO-108-4-1142
Insulin degradation by hepatocytes in primary culture.
W. Duckworth (1981)
10.1023/A:1016418523014
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
Total synthesis of crystalline insulin.
Y. Kung (1966)
[Crystalline and amorphous insulin and zinc compounds with prolonged action].
K. HALLAS-MØLLER (1951)
Insulin therapy in type 2 diabetes mellitus
C. Casanova (2010)
XXX. Synthesis of the insulin sequence B 13-30
D Gillessen (1963)
10.1615/CRITREVTHERDRUGCARRIERSYST.V19.I6.10
The colon as a possible target for orally administered peptide and protein drugs.
S. Haupt (2002)
10.2337/DIABETES.49.6.999
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.
P. Kurtzhals (2000)
10.1248/BPB.16.68
Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.
M. Morishita (1993)
10.1042/BJ0600541
The disulphide bonds of insulin.
A. Ryle (1955)
10.1016/J.JCONREL.2005.05.022
An enteric-coated dry emulsion formulation for oral insulin delivery.
Eiichi Toorisaka (2005)
10.1016/J.JCONREL.2003.12.022
Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
K. Nakamura (2004)
10.1016/S0378-5173(02)00674-9
Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion.
Eiichi Toorisaka (2003)
10.1007/978-1-4899-1236-7_11
Insulin structure and stability.
J. Brange (1993)
Systemic absorption of insulin delivered topically to the rat eye.
D. Pillion (1991)
Oral pharmaceuticals based on jettable microemulsions containing oils and drugs and surfactants and aqueous solutions. Application: US patent
MP Gore (2005)
Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
Y. Zhang (2001)
10.1016/0006-291X(86)90579-6
Phytohemagglutinin (PHA) activated human T-lymphocytes: concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH).
C. Buffington (1986)
10.1021/BI00416A053
Insulin-metal ion interactions: the binding of divalent cations to insulin hexamers and tetramers and the assembly of insulin hexamers.
F. Coffman (1988)
10.1038/259369A0
Receptor-binding region of insulin
R. A. Pullen (1976)
10.1002/DMR.5610090407
The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: the Finnish experience.
H. Akerblom (1993)
10.1345/aph.1A301
Insulin Glargine: A New Basal Insulin
T. Levien (2002)
Insulin glargine (Lantus).
D. Owens (2002)
10.2337/DIACARE.27.7.1798
Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop.
G. Alberti (2004)
10.2337/DIACARE.25.2.275
Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
C. Rohlfing (2002)
10.1016/J.ADDR.2007.08.019
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.
J. Brange (1992)
10.1080/10717540500309040
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
J. Varshosaz (2006)
10.1152/AJPENDO.00359.2007
Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion.
R. Bertram (2007)
10.1172/JCI115558
Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.
N. Nurjhan (1992)
10.1007/BF01928732
Control of diabetes with polyacrylamide implants containing insulin
B. K. Davis (2005)
10.1089/DIA.2006.0019
Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.
J. Guevara-Aguirre (2007)
10.3109/10717549809052027
Insulin delivery through the ocular route.
R. Srinivasan (1998)
10.1211/0022357021778736
In‐vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion
Suchat Watnasirichaikul (2002)
10.1248/CPB.44.235
Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
T. Uchida (1996)
10.1016/J.JCONREL.2003.12.017
Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
A. Krauland (2004)
10.1248/CPB.29.810
New mucosal dosage form of insulin.
M. Ishida (1981)
10.1073/PNAS.57.2.473
The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma.
D. Steiner (1967)
10.1016/s0021-9258(19)47058-0
Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
F. Stentz (1989)
Prolonged release of insulin by cholesterol-matrix implant
PY Wang (1987)
10.1016/S0378-5173(00)00411-7
The dose-related hypoglycemic effects of insulin emulsions incorporating highly purified EPA and DHA.
M. Morishita (2000)
Synthesis of the peptide fragments of the B-chain of insulin. X. Synthesis of a derivative of the C-terminal docosapeptide of the B-chain of insulin.
Y. Kung (1966)
Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
C. Xia (2000)
10.1016/S0168-3659(02)00276-6
Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens.
M. Murillo (2002)
The top pharmaceuticals that changed the world
A. Thayer (2005)
10.1016/S0006-3495(99)77012-8
The lifetime of insulin hexamers.
U. Hassiepen (1999)
10.1038/371130A0
A genome-wide search for human type 1 diabetes susceptibility genes
J. Davies (1994)
10.2337/DIACARE.28.7.1630
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
J. Skyler (2005)
10.1016/J.JCONREL.2004.10.032
Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
Byoung-Yun Kim (2005)
10.1016/J.LFS.2004.05.027
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Z. Değim (2004)
10.1016/S0378-5173(01)00588-9
Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids.
R. Mitra (2001)
10.1073/PNAS.76.1.106
Expression in Escherichia coli of chemically synthesized genes for human insulin.
D. Goeddel (1979)
10.1016/S0168-3659(02)00060-3
Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
Y. Yamaguchi (2002)
10.2337/DIACARE.28.3.632
Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes.
A. Ceriello (2005)
10.1081/DDC-120021771
Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Ken Katayama (2003)
10.1152/AJPENDO.1996.270.4.E709
Glucose production, recycling, and gluconeogenesis in normals and diabetics: a mass isotopomer [U-13C]glucose study.
J. Tayek (1996)
10.1021/BI00436A046
Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin.
N. Kaarsholm (1989)
10.2337/DIACARE.27.7.1761
Tests of glycemia in diabetes.
D. Goldstein (2004)
10.2337/DIABETES.44.6.652
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group.
H. Hyöty (1995)
10.7326/0003-4819-10-9-1335
Crystalline insulin.
D. Scott
10.1080/02652040400015403
Nasal delivery of insulin using chitosan microspheres
J. Varshosaz (2004)
The ocular route for systemic insulin delivery in the albino rabbit.
A. Yamamoto (1989)
10.1007/978-94-010-9595-2_10
The structure of a new hexameric form of human insulin
G. D. Smith (1988)
10.2337/diab.36.9.1068
Prolonged Release of Insulin by Cholesterol-Matrix Implant
P. Wang (1987)
Crystal Structure of a ProlongedActing Insulin with Albumin-Binding Properties. Biochemistry
JL Whittingham (1997)
10.1038/1991095A0
Preparation of an Insulin A Chain Derivative with an Intact Intra-chain Disulphide Bond
J. Meienhofer (1963)
10.1016/s0021-9258(18)85220-6
ON THE PREPARATION OF INSULIN
M. Somogyi (1924)
10.1016/J.JCONREL.2005.10.029
Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
M. Morishita (2006)
10.1038/414782a
Global and societal implications of the diabetes epidemic
P. Zimmet (2001)
10.1016/s0021-9258(19)39381-0
1H NMR spectrum of the native human insulin monomer. Evidence for conformational differences between the monomer and aggregated forms.
M. Roy (1990)
10.1016/S1359-6446(03)02623-0
Peptide and protein drug delivery to and into tumors: challenges and solutions.
V. Torchilin (2003)
10.1021/BI00160A026
Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry.
D. Müller (1992)
10.1177/039139889001300701
A Case for Oral Insulin Therapy in the Prevention of Diabetic Micro- and Macroangiopathy
G. Gwinup (1990)
10.1023/A:1015808023310
Nasal Membrane and Intracellular Protein and Enzyme Release by Bile Salts and Bile Salt-Fatty Acid Mixed Micelles: Correlation with Facilitated Drug Transport
Z. Shao (2004)
10.1136/bmj.311.7010.913
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins
K. Kyvik (1995)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1016/S0149-2918(03)80156-X
Insulin glargine: a systematic review of a long-acting insulin analogue.
F. Wang (2003)
10.1016/S0169-409X(98)00070-2
Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus.
Graves (1999)
10.1016/0026-0495(87)90031-X
Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity.
R. Firth (1987)
Endosomes degrade insulin.
J. Fawcett (1993)
10.1038/nrd836
New horizons — alternative routes for insulin therapy
D. Owens (2002)
assignee. Oral insulin emulsion or self-microemulsion and capsule with colon-specific release. Application: CN patent
J Zhang (2005)
Noring IM, inventors; (Novo Terapeutisk Laboratorium A/S). assignee. Crystallization of insulin using freeze-dried insulin as seeding material
J Schlichtkrull (1958)
10.1021/bi960292
Solution structure of an engineered insulin monomer at neutral pH.
H. Olsen (1996)



Semantic Scholar Logo Some data provided by SemanticScholar